OncoSeek: A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens
(abstr)
Routbort MJ, Handal BA, Patel KP, et al: OncoSeek: A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens. J Mol Diagn 14:747, 2012 (abstr)
Enabling a genetically informed approach to cancer medicine: A retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel
Johnson DB, Dahlman KH, Knol J, et al: Enabling a genetically informed approach to cancer medicine: A retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist 19: 616-622, 2014
Concordance of genomic alterations between primary and recurrent breast cancer
Meric-Bernstam F, Frampton GM, Ferrer-Lozano J, et al: Concordance of genomic alterations between primary and recurrent breast cancer. Mol Cancer Ther 13:1382-1389, 2014
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Frampton GM, Fichtenholtz A, Otto GA, et al: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31:1023-1031, 2013
Clinical next-generation sequencing in patients with non-small cell lung cancer
Hagemann IS, Devarakonda S, Lockwood CM, et al: Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer 121:631-639, 2015
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER)
André F, Bachelot T, Commo F, et al: Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol 15:267-274, 2014
Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials
Lovly CM, Dahlman KB, Fohn LE, et al: Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One 7:e35309, 2012